Document Detail


Angiogenic factor AGGF1 promotes therapeutic angiogenesis in a mouse limb ischemia model.
MedLine Citation:
PMID:  23110058     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
BACKGROUND: Peripheral arterial disease (PAD) is a common disease accounting for about 12% of the adult population, and causes significant morbidity and mortality. Therapeutic angiogenesis using angiogenic factors has been considered to be a potential treatment option for PAD patients. In this study, we assessed the potential of a new angiogenic factor AGGF1 for therapeutic angiogenesis in a critical limb ischemia model in mice for PAD.
METHODS AND RESULTS: We generated a unilateral hindlimb ischemia model in mice by ligation of the right common iliac artery and femoral artery. Ischemic mice with intrasmuscular administration of DNA for an expression plasmid for human AGGF1 (AGGF1 group) resulted in increased expression of both AGGF1 mRNA and protein after the administration compared with control mice with injection of the empty vector (control group). Color PW Doppler echocardiography showed that the blood flow in ischemic hindlimbs was significantly increased in the AGGF1 group compared to control mice at time points of 7, 14, and 28 days after DNA administration (n = 9/group, P = 0.049, 0.001, and 0.001, respectively). Increased blood flow in the AGGF1 group was correlated to increased density of CD31-positive vessels and decreased necrosis in muscle tissues injected with AGGF1 DNA compared with the control tissue injected with the empty vector. Ambulatory impairment was significantly reduced in the AGGF1 group compared to the control group (P = 0.004). The effect of AGGF1 was dose-dependent. At day 28 after gene transfer, AGGF1 was significantly better in increasing blood flow than FGF-2 (P = 0.034), although no difference was found for tissue necrosis and ambulatory impairment.
CONCLUSIONS: These data establish AGGF1 as a candidate therapeutic agent for therapeutic angiogenesis to treat PAD.
Authors:
Qiulun Lu; Yihong Yao; Yufeng Yao; Shizhi Liu; Yuan Huang; Shan Lu; Ying Bai; Bisheng Zhou; Yan Xu; Lei Li; Nan Wang; Li Wang; Jie Zhang; Xiang Cheng; Gangjian Qin; Wei Ma; Chengqi Xu; Xin Tu; Qing Wang
Related Documents :
20174638 - Therapeutic efficacy of human hepatocyte transplantation in a scid/upa mouse model with...
23933568 - Metastatic breast carcinoma induces vascular endothelial dysfunction in balb-c mice: ro...
11194178 - Ampelopsis brevipedunculata (vitaceae) extract inhibits a progression of carbon tetrach...
25358268 - Core binding factor β of osteoblasts maintains cortical bone mass via stabilization of ...
19535048 - Highly expressed recombinant human follicle-stimulating hormone from chinese hamster ov...
19779008 - Using complementary and alternative medicines to target the host response during severe...
Publication Detail:
Type:  Journal Article; Research Support, Non-U.S. Gov't     Date:  2012-10-23
Journal Detail:
Title:  PloS one     Volume:  7     ISSN:  1932-6203     ISO Abbreviation:  PLoS ONE     Publication Date:  2012  
Date Detail:
Created Date:  2012-10-30     Completed Date:  2013-04-17     Revised Date:  2013-07-11    
Medline Journal Info:
Nlm Unique ID:  101285081     Medline TA:  PLoS One     Country:  United States    
Other Details:
Languages:  eng     Pagination:  e46998     Citation Subset:  IM    
Affiliation:
Key Laboratory of Molecular Biophysics of the Ministry of Education, College of Life Science and Technology, Center for Human Genome Research, Cardio-X Institute, Huazhong University of Science and Technology, Wuhan, People's Republic of China.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Angiogenic Proteins / genetics,  metabolism*
Animals
Hindlimb / metabolism,  pathology*
Humans
Ischemia / therapy*
Mice
Neovascularization, Physiologic / genetics,  physiology*
Peripheral Arterial Disease / metabolism,  therapy
Chemical
Reg. No./Substance:
0/AGGF1 protein, human; 0/Angiogenic Proteins
Comments/Corrections

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Genome-wide identification of reverse complementary microRNA genes in plants.
Next Document:  Fish and mammalian phagocytes differentially regulate pro-inflammatory and homeostatic responses in ...